Advertisement

January 16, 2022

January 11, 2022

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

  • Yusuke Kitagawa,
  • Takashi Akiyoshi,
  • Noriko Yamamoto,
  • ...
  • Toru Hirota,
  • Tetsuo Noda,
  • Hiroshi Kawachi
Published online: January 11, 2022

January 7, 2022

December 31, 2021

December 26, 2021

December 20, 2021

Assessment of Metastatic Colorectal Cancer Patients’ Preferences for Biologic Treatments in Germany Using a Discrete Choice Experiment

  • Volker Heinemann,
  • Moushmi Singh,
  • Fränce Hardtstock,
  • ...
  • Andrea Lebioda,
  • Tanja Schaller-Kranz,
  • Robert Bartsch
Published online: December 20, 2021

December 4, 2021

November 30, 2021

Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer

  • Konstantinos Kamposioras,
  • Kok Haw Jonathan Lim,
  • Joseph Williams,
  • ...
  • Lauren Bayles,
  • Jennifer King,
  • Mark Saunders
Published online: November 30, 2021

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

  • Irene S. Yu,
  • Zamzam Al-Hashami,
  • Parv Chapani,
  • ...
  • Sharlene Gill,
  • Heather C. Stuart,
  • Jonathan M. Loree
Published online: November 30, 2021

November 28, 2021

Targeting Hyaluronic Acid and Peritoneal Dissemination in Colorectal Cancer

  • Faris Soliman,
  • Lin Ye,
  • Wenguo Jiang,
  • Rachel Hargest
Published online: November 28, 2021

Colorectal Cancer Screening in the Elderly: Is Age Just a Number?

  • Waed Alswealmeen,
  • Lili Sadri,
  • Gabrielle Perrotti,
  • ...
  • Soo Y. Kim,
  • David M. Zebley,
  • Steven A. Fassler
Published online: November 28, 2021

Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review

  • Bernard J. Smilde,
  • Anne F. Louwerenburg,
  • Marije M. van Santen,
  • Mathijs P. Hendriks
Published online: November 28, 2021

mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis

  • Miaomiao Ding,
  • Jianwei Zhang,
  • Huabin Hu,
  • ...
  • Jianxia Li,
  • Weiwei Li,
  • Yanhong Deng
Published online: November 28, 2021

Neoadjuvant Therapy for Rectal Cancer: Updates From the UNICANCER-PRODIGE 23 Trial

  • Francesca De Felice,
  • Daniela Musio,
  • Vincenzo Tombolini,
  • Enrico Cortesi
Published online: November 28, 2021

Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol

  • Mehraneh D. Jafari,
  • Joseph C. Carmichael,
  • Farshid Dayyani,
  • ...
  • Lari Wenzel,
  • Jason A. Zell,
  • Alessio Pigazzi
Published online: November 28, 2021

November 27, 2021

November 20, 2021

Biomarkers in Locally Advanced Rectal Cancer: A Review

  • Shehara Mendis,
  • Yat Hang To,
  • Jeanne Tie
Published online: November 20, 2021

November 18, 2021

The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead

  • Christopher J. Anker,
  • Nataniel H. Lester-Coll,
  • Dmitriy Akselrod,
  • Peter A. Cataldo,
  • Steven Ades
Published online: November 18, 2021

Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer

  • Jeongshim Lee,
  • Woong Sub Koom,
  • Hwa Kyung Byun,
  • ...
  • Sang Joon Shin,
  • Kangpyo Kim,
  • Jee Suk Chang
Published online: November 18, 2021

November 14, 2021

Tumor Regression Grade as a Prognostic Factor in Metastatic Colon Cancer Following Preoperative Chemotherapy

  • Yufei Yang,
  • Dakui Luo,
  • Ruoxin Zhang,
  • Sanjun Cai,
  • Qingguo Li,
  • Xinxiang Li
Published online: November 14, 2021

November 13, 2021

MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response

  • David D.B. Bates,
  • Maria El Homsi,
  • Kevin J. Chang,
  • Neeraj Lalwani,
  • Natally Horvat,
  • Shannon P. Sheedy
Published online: November 13, 2021

November 4, 2021

Current State of Neoadjuvant Radiotherapy for Rectal Cancer

  • Sweet Ping Ng,
  • Samuel Y Ngan,
  • Trevor Leong
Published online: November 04, 2021

October 23, 2021

Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy

  • Joseph Sia,
  • Wei Mou Lim,
  • Ryan Anthony Agas,
  • ...
  • Alexander Heriot,
  • Trevor Leong,
  • Samuel Y Ngan
Published online: October 23, 2021

October 17, 2021

The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine

  • Romy Aarnoutse,
  • Janine Ziemons,
  • Judith de Vos-Geelen,
  • ...
  • Sander S. Rensen,
  • John Penders,
  • Marjolein L. Smidt
Published online: October 17, 2021
Open Access

October 16, 2021

Novel Immunological Approaches in the Treatment of Locally Advanced Rectal Cancer

  • Hideaki Bando,
  • Yuichiro Tsukada,
  • Masaaki Ito,
  • Takayuki Yoshino
Published online: October 16, 2021
Open Access

Localized Well-Differentiated Rectal Neuroendocrine Tumors – Where Are We in 2021?

  • Larissa Costa Amorim,
  • Artur Rodrigues Ferreira,
  • Rodrigo Oliva Perez,
  • Renata D'Alpino Peixoto
Published online: October 16, 2021

Defibrotide for Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia After Oxaliplatin-Based Hepatic Intra-Arterial Chemotherapy: A Case Report

  • Amaury Druet,
  • Jean-François Mosnier,
  • Erwan Corbineau,
  • Tamara Matysiak-Budnik,
  • Yann Touchefeu,
  • Caroline Viala
Published online: October 16, 2021

October 8, 2021

Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer

  • Nicolette Taku,
  • Y. Nancy Yi-Qian,
  • George J. Chang,
  • ...
  • Van K. Morris,
  • Scott Kopetz,
  • Prajnan Das
Published online: October 08, 2021

October 3, 2021

October 2, 2021

Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer

  • Breanne Cadham,
  • Brent Parker,
  • Yaling Yin,
  • ...
  • Jonathan M. Loree,
  • Winson Y. Cheung,
  • Janine M. Davies
Published online: October 02, 2021

October 1, 2021

Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients

  • Meijiao Zhou,
  • Trevor D. Thompson,
  • Hui-Yi Lin,
  • ...
  • Mei-Chin Hsieh,
  • Lori A. Pollack,
  • Xiao-Cheng Wu
Published online: October 01, 2021
Open Access

September 14, 2021

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

  • Gunnar Folprecht,
  • Anke Reinacher-Schick,
  • Jürgen Weitz,
  • ...
  • Michael Kramer,
  • Christian Thiede,
  • Andrea Tannapfel
Published online: September 14, 2021
Advertisement